"Smart" nickel oxide based core-shell nanoparticles for combined chemo and photodynamic cancer therapy

27Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

We report "smart" nickel oxide nanoparticles (NOPs) as multimodal cancer therapy agent. Water-dispersible and light-sensitive NiO core was synthesized with folic acid (FA) connected bovine serum albumin (BSA) shell on entrapped doxorubicin (DOX). The entrapped drug from NOP-DOX@BSA-FA was released in a sustained way (64 hours, pH=5.5, dark conditions) while a robust release was found under red light exposure (in 1/2 hour under λmax = 655 nm, 50 mW/cm2, at pH=5.5). The cell viability, thiobarbituric acid reactive substances and diphenylisobenzofuran assays conducted under light and dark conditions revealed a high photodynamic therapy potential of our construct. Furthermore, we found that the combined effect of DOX and NOPs from NOP-DOX@BSA-FA resulted in cell death approximately eightfold high compared to free DOX. We propose that NOP-DOX@BSA-FA is a potential photodynamic therapy agent and a collective drug delivery system for the systemic administration of cancer chemotherapeutics resulting in combination therapy.

Cite

CITATION STYLE

APA

Bano, S., Nazir, S., Munir, S., Fahad Al-Ajmi, M., Afzal, M., & Mazhar, K. (2016). “Smart” nickel oxide based core-shell nanoparticles for combined chemo and photodynamic cancer therapy. International Journal of Nanomedicine, 11, 3159–3166. https://doi.org/10.2147/IJN.S106533

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free